BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32680999)

  • 1. Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment.
    Marijan S; Markotić A; Mastelić A; Režić-Mužinić N; Pilkington LI; Reynisson J; Čulić VČ
    Sci Rep; 2020 Jul; 10(1):11876. PubMed ID: 32680999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Thieno [2,3-
    Pervan M; Marijan S; Markotić A; Pilkington LI; Haverkate NA; Barker D; Reynisson J; Meić L; Radan M; Čikeš Čulić V
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-
    Mastelić A; Čikeš Čulić V; Režić Mužinić N; Vuica-Ross M; Barker D; Leung EY; Reynisson J; Markotić A
    Drug Des Devel Ther; 2017; 11():759-769. PubMed ID: 28352152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells.
    Liang YJ; Ding Y; Levery SB; Lobaton M; Handa K; Hakomori SI
    Proc Natl Acad Sci U S A; 2013 Mar; 110(13):4968-73. PubMed ID: 23479608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.
    Jafari SM; Joshaghani HR; Panjehpour M; Aghaei M
    Cell Oncol (Dordr); 2018 Feb; 41(1):61-72. PubMed ID: 29218545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.
    Manupati K; Dhoke NR; Debnath T; Yeeravalli R; Guguloth K; Saeidpour S; De UC; Debnath S; Das A
    FEBS J; 2017 Jun; 284(12):1830-1854. PubMed ID: 28398698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.
    Liang YJ; Wang CY; Wang IA; Chen YW; Li LT; Lin CY; Ho MY; Chou TL; Wang YH; Chiou SP; Lin YJ; Yu J
    Oncotarget; 2017 Jul; 8(29):47454-47473. PubMed ID: 28537895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
    Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J
    Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor-positive breast cancer cells.
    Kurebayashi J; Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T
    Cancer Sci; 2017 May; 108(5):918-930. PubMed ID: 28211214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC).
    Graham ÉA; Mallet JF; Jambi M; Nishioka H; Homma K; Matar C
    Cancer Biol Ther; 2017 Oct; 18(10):765-774. PubMed ID: 28886271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer activity of a monobenzyltin complex C1 against MDA-MB-231 cells through induction of Apoptosis and inhibition of breast cancer stem cells.
    Fani S; Kamalidehghan B; Lo KM; Nigjeh SE; Keong YS; Dehghan F; Soori R; Abdulla MA; Chow KM; Ali HM; Hajiaghaalipour F; Rouhollahi E; Hashim NM
    Sci Rep; 2016 Dec; 6():38992. PubMed ID: 27976692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously.
    Hii LW; Chung FF; Soo JS; Tan BS; Mai CW; Leong CO
    Breast Cancer Res Treat; 2020 Feb; 179(3):615-629. PubMed ID: 31784862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells.
    Velázquez-Quesada I; Ruiz-Moreno AJ; Casique-Aguirre D; Aguirre-Alvarado C; Cortés-Mendoza F; de la Fuente-Granada M; García-Pérez C; Pérez-Tapia SM; González-Arenas A; Segura-Cabrera A; Velasco-Velázquez MA
    Drug Des Devel Ther; 2020; 14():1799-1811. PubMed ID: 32494122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
    Peng L; Li FX; Shao WF; Xiong JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70.
    Hyun SY; Le HT; Min HY; Pei H; Lim Y; Song I; Nguyen YTK; Hong S; Han BW; Lee HY
    Theranostics; 2021; 11(6):2932-2952. PubMed ID: 33456581
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions.
    Liang YJ
    Glycoconj J; 2022 Apr; 39(2):177-195. PubMed ID: 35267131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anticancer Os(II) bathophenanthroline complex as a human breast cancer stem cell-selective, mammosphere potent agent that kills cells by necroptosis.
    Novohradsky V; Markova L; Kostrhunova H; Trávníček Z; Brabec V; Kasparkova J
    Sci Rep; 2019 Sep; 9(1):13327. PubMed ID: 31527683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
    Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
    Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Synergistic Effect of Sildenafil and Green Tea Polyphenols on Breast Cancer Stem Cell-like Cells and their Parental Cells: A Potential Novel Therapeutic Approach.
    Sharif MS; Mohseni HS; Khanavi M; Ghadami S; Jafarzadeh E; Tavajohi S; Aliebrahimi S; Ostad SN
    Anticancer Agents Med Chem; 2024 Feb; 24(4):304-315. PubMed ID: 37957912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.